GCTK
Glucotrack, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · IL
$0.71
−2.43%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.73
From 52W high−99.35%
Volume74679.00
Market cap$720145.23
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.73
From 52W high
−99.35%
Volume
74679.00
Market cap
$720145.23
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.0x
P/E (TTM)
—
RSI (14)
25.2
MomentumView details →
1D Return
−2.43%
YTD Return
−98.78%
SummaryUpdated Jun 1, 2026
GlucoTrack, Inc. (NASDAQ:GCTK) is an Israeli medical device company founded in 2001 and headquartered in Or Yehuda, Israel. Originally established as Integrity Applications, Inc., the company rebranded to GlucoTrack in November 2021 to better reflect its focus on glucose monitoring technology. The company went public in April 2013 and specializes in developing non-invasive glucose monitoring devices for people with diabetes and pre-diabetes. Despite over two decades of development, GlucoTrack has yet to generate commercial revenue and remains in the research and development phase of bringing its flagship product to market.
Similar companies
Latest newsMore news →
Glucotrack, Inc. amended its September Notes to remove downward Floor Price adjustment provisions, make the Floor Price an absolute floor, and require any True-Up Amount to be paid only in cash.21d agoGlucotrack, Inc. announced the pricing of a $3 million public offering.26d agoGlucoTrack Inc's subsidiary Lokahi Therapeutics signed its first external, fee-for-service partnership.26d ago